KOPRAN
Back to Cashflow Statement
|
KOPRAN Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-20 Cr | ₹123 Cr | ₹-35 Cr | ₹-18 Cr | ₹-0.58 Cr |
What is the latest Cash Flow from Financing Activities ratio of KOPRAN ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2023 | ₹-20 Cr |
Mar2022 | ₹123 Cr |
Mar2021 | ₹-35 Cr |
Mar2020 | ₹-18 Cr |
Mar2019 | ₹-0.58 Cr |
How is Cash Flow from Financing Activities of KOPRAN Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2023 | ₹-20 Cr | Negative | |
Mar2022 | ₹123 Cr | Positive | |
Mar2021 | ₹-35 Cr | Negative | |
Mar2020 | ₹-18 Cr | Negative | |
Mar2019 | ₹-0.58 Cr | - |
Compare Cash Flow from Financing Activities of peers of KOPRAN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KOPRAN | ₹1,179.9 Cr | -7.3% | -9.7% | 63.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,026.0 Cr | 0.5% | -5.7% | 55.1% | Stock Analytics | |
CIPLA | ₹114,925.0 Cr | 1.1% | -4.4% | 55.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,128.0 Cr | -0.7% | 9.4% | 21.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,109.0 Cr | 0.1% | 1.1% | 28.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹102,736.0 Cr | 6% | 2.8% | 93.1% | Stock Analytics |
KOPRAN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KOPRAN | -7.3% |
-9.7% |
63.2% |
SENSEX | 0.2% |
-0.2% |
20.9% |
You may also like the below Video Courses